Bp (LON:BP) “Buy” Rating Reiterated by HSBC; With GBX 610.00 Target; First Fiduciary Investment Counsel Trimmed Novartis Ag Adr (NVS) Stake

BP p.l.c. (LON:BP) Logo

In a report revealed to investors and clients on Tuesday, 15 May, Bp (LON:BP) stock had its “Buy” Rating maintained by equity research analysts at HSBC. They currently have a GBX 610.00 price target on company. HSBC’s target suggests a potential upside of 5.68% from the company’s last stock close.

First Fiduciary Investment Counsel Inc decreased Novartis Ag Adr (NVS) stake by 2.06% reported in 2017Q4 SEC filing. First Fiduciary Investment Counsel Inc sold 4,805 shares as Novartis Ag Adr (NVS)’s stock declined 4.22%. The First Fiduciary Investment Counsel Inc holds 228,028 shares with $19.15 million value, down from 232,833 last quarter. Novartis Ag Adr now has $180.71 billion valuation. The stock decreased 1.12% or $0.88 during the last trading session, reaching $77.45. About 2.32 million shares traded or 38.82% up from the average. Novartis AG (NYSE:NVS) has risen 5.79% since May 16, 2017 and is uptrending. It has underperformed by 5.76% the S&P500.

Among 16 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 4 Sell and 7 Hold. Therefore 31% are positive. Novartis Ag has $110 highest and $7700 lowest target. $96.80’s average target is 24.98% above currents $77.45 stock price. Novartis Ag had 36 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Novartis AG (NYSE:NVS) has “Buy” rating given on Wednesday, March 8 by Societe Generale. Leerink Swann maintained the stock with “Hold” rating in Thursday, June 22 report. The rating was maintained by J P Morgan Chase Co on Friday, June 16 with “Neutral”. The stock has “Sell” rating by Bank of America on Wednesday, December 6. The firm earned “Hold” rating on Monday, September 11 by Cowen & Co. The firm earned “Hold” rating on Tuesday, July 18 by Cowen & Co. On Wednesday, August 9 the stock rating was maintained by Cowen & Co with “Hold”. The firm has “Overweight” rating given on Wednesday, July 26 by Morgan Stanley. The stock of Novartis AG (NYSE:NVS) has “Hold” rating given on Monday, July 10 by Cowen & Co. The rating was downgraded by Barclays Capital on Wednesday, October 25 to “Sell”.

More notable recent Novartis AG (NYSE:NVS) news were published by: Seekingalpha.com which released: “Novartis lawyer out amid Cohen payments” on May 16, 2018, also Seekingalpha.com with their article: “Senators press AT&T for detail on Cohen payments” published on May 14, 2018, Seekingalpha.com published: “AT&T confirms it paid Michael Cohen” on May 09, 2018. More interesting news about Novartis AG (NYSE:NVS) were released by: Nasdaq.com and their article: “Momenta Pharmaceuticals Contemplates Its Future” published on May 15, 2018 as well as Seekingalpha.com‘s news article titled: “Novartis Q1 2018: Recent Sell-Off Seems Overdone” with publication date: April 24, 2018.

Analysts await Novartis AG (NYSE:NVS) to report earnings on July, 17. They expect $1.31 earnings per share, up 8.26% or $0.10 from last year’s $1.21 per share. NVS’s profit will be $3.06B for 14.78 P/E if the $1.31 EPS becomes a reality. After $1.28 actual earnings per share reported by Novartis AG for the previous quarter, Wall Street now forecasts 2.34% EPS growth.

The stock increased 0.33% or GBX 1.9 during the last trading session, reaching GBX 579.1. About 5.80 million shares traded. BP p.l.c. (LON:BP) has 0.00% since May 16, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 26 analysts covering BP PLC (LON:BP), 15 have Buy rating, 1 Sell and 10 Hold. Therefore 58% are positive. BP PLC has GBX 675 highest and GBX 325 lowest target. GBX 522.32’s average target is -9.80% below currents GBX 579.1 stock price. BP PLC had 424 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by Canaccord Genuity with “Hold” on Friday, August 28. The firm earned “Overweight” rating on Tuesday, June 20 by Barclays Capital. The rating was maintained by Jefferies with “Hold” on Wednesday, November 2. The firm earned “Buy” rating on Wednesday, July 27 by Beaufort Securities. The company was maintained on Wednesday, April 4 by BNP Paribas. Citigroup maintained it with “Buy” rating and GBX 510 target in Wednesday, March 1 report. Beaufort Securities maintained BP p.l.c. (LON:BP) on Wednesday, February 3 with “Buy” rating. Kepler Cheuvreux maintained the shares of BP in report on Wednesday, November 1 with “Hold” rating. Deutsche Bank maintained the stock with “Buy” rating in Monday, February 1 report. On Monday, June 12 the stock rating was maintained by JP Morgan with “Overweight”.

BP p.l.c. operates as an integrated gas and oil firm worldwide. The company has market cap of 115.46 billion GBP. It operates through three divisions: Upstream, Downstream, and Rosneft. It has a 33.87 P/E ratio. The Upstream segment engages in the oil and natural gas exploration, field development, and production; midstream transportation, storage, and processing; and marketing and trading of natural gas, including liquefied natural gas , and power and natural gas liquids (NGLs).

Novartis AG (NYSE:NVS) Ratings Chart